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The importance of measuring impulsiveness in patients with addiction
problemsAn impulse may be sudden, or it may be a steady rise in
tension until it reaches a climax, whereupon it is acted out
without regard to self or others. Impulsivity is actually evi-
denced behaviorally as carelessness, an underestimated sense
of harm, extroversion, impatience, including the inability to
delay gratification, and a tendency toward risk-taking, plea-
sure, and sensation seeking. Impulsivity has been defined as
the failure to resist an impulse, drive, or temptation that is
potentially harmful to oneself or others, and is a defining
characteristic of a wide spectrum of psychiatric diseases,
including attention deficit hyperactivity disorder, bipolar
spectrum disorders, impulse control disorders, cluster B
personality disorders, and addiction. Three cognitive compo-
nents play an important role in modulating impulsivity:
inability to delay gratification, distractibility, and disinhibi-
tion.1 In contrast to compulsivity, which is driven by an effort
to reduce anxiety, impulsivity is driven by an effort to obtain
arousal and gratification. However, individuals with both
behavior problems have in common the inability to refrain
from repetitive behaviors.
Drug addiction is a chronic relapsing disorder, characterized
by a cycle of intoxication, binging, withdrawal, and craving,
which results in excessive drug use despite adverse conse-
quences. Drugs that have the potential for abuse and addiction
increase dopamine (DA) levels in the reward circuit, and this
characteristic is believed to underlie their reward effects.
Previous clinical studies of addiction have focused on the
midbrain DA-rich areas and the basal ganglia structures, which
are involved in reward and conditioning. Recent clinical studies,
however, have focused on the role of the prefrontal cortex (PFC)
in addiction. Disrupted PFC function contributes to impulsivity,
compulsivity, risk-taking, and impaired self-monitoring in
addicts, and leads to a syndrome of impaired response inhibition
and salience attribution, characterized by attributing excessive
salience to the drug, drug cues, decreased sensitivity to nondrug
rewards, and decreased ability to inhibit maladaptive or risky
behaviors. As a result, addicts tend to compulsively and
impulsively seek and use the drug, lose the ability to limit intake,
and suffer from a negative emotional state when access to the
drug is prevented. As the addiction progresses, there is a shift
from positive reinforcement driving the motivated behavior to
negative reinforcement driving the motivated behavior (from1726-4901/$ - see front matter Copyright  2012 Elsevier Taiwan LLC and the C
http://dx.doi.org/10.1016/j.jcma.2012.10.003liking to wanting). Thus, drug addiction has been conceptual-
ized as a disorder which progresses from impulsivity to
compulsivity. In addition, results from both human and animal
studies have confirmed the association between addiction and
impulsivity using different techniques.2
Impulsivity, expressed as impulsive decision-making and
inhibitory failure to stop, plays an important role during
different phases of addiction. In the beginning, impulsivity
leads to drug abuse, which in turn increases impulsivity,
contributing to risky, disinhibiting behaviors.3,4 Furthermore,
chronic use of drugs of abuse lowers D2 DA receptor (DRD2)
levels, and thus impairs PFC control of impulsivity. Animal
studies first explored the connection between DRD2 and
behavioral control, and the results of such studies clearly show
a negative correlation between DRD2 and impulsivity, as well
as a negative correlation between impulsivity and drug self-
administration.5,6 In human cases with addiction problems,
lower striatal DRD2 levels significantly correlated with lower
brain glucose metabolism in key regions of the PFC, such as
the orbitofrontal cortex (involved with salience attribution)
and cingulate gyrus (involved with inhibitory control),
disruption of which results in compulsivity and impulsivity.7,8
An association was also found between reduced baseline PFC
and reduced striatal DRD2 levels in cases with addiction
problems. This finding evinces the strong connections between
neuroadaptations in PFC pathways and downstream dysfunc-
tions in the DA reward and motivational systems, likely
because of the influence of PFC on impulsivity.9
As for another important phase of addiction, craving, there
are individual differences in the degree of cue-elicited craving.
Impulsivity is again found to be one of the important personal
factors. Individuals with higher impulsivity appeared to show
ineffective response inhibition and more craving for
substance-related cues.10 Another recent study, however,
suggested a need to explore individual differences in
compulsivity when addressing the links between craving and
impulsivity in patients with opiate dependence, because the
results of this study revealed that individual differences in
compulsivity mediated the association between craving and
inhibitory control in Stroop performance.11 Different deficits
of impulse control may perhaps motivate drug use in a variety
of ways.hinese Medical Association. All rights reserved.
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(BIS-11) is one of the most commonly used measures to
evaluate the symptoms of impulsivity and aggressions.12 The
BIS-11 measures impulsivity in terms of three domains: motor
impulsiveness, nonplanning impulsiveness, and attentional
impulsiveness. By evaluating a patient’s severity in each of the
three domains, the scale is able to provide a description of
impulsivity in individuals. It is a clinician-rated scale, and
requires 10e15 minutes to complete the 30 items. It is easy to
administer and widely used.
As a variety of findings in the literature related to alcohol
and stimulants have used the BIS-11 measures to examine the
role of impulsivity in addiction,13 a study to evaluate the
reliability and validity of the Chinese version of BIS-11 in
abstinent, opioid-dependent cases has been carried out.14 The
report may help clinicians in Taiwan to detect individuals with
a high risk of developing addiction problems, and to measure
treatment retention and the possibility of relapse objectively.
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